tiprankstipranks
Trending News
More News >
Yantai North Andre Juice Co Ltd Class H (HK:2218)
:2218

Yantai North Andre Juice Co (2218) AI Stock Analysis

Compare
1 Followers

Top Page

HK:2218

Yantai North Andre Juice Co

(2218)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
HK$15.50
▼(-2.21% Downside)
Score is driven primarily by strong financial performance (rapid TTM growth, solid margins, and a debt-free balance sheet), partially offset by cash flow volatility and margin compression versus 2023. Technical indicators are mixed with a broader downtrend (below 50/100/200DMA and negative MACD), while valuation is supportive with a moderate P/E and ~2% dividend yield.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for products and effective market penetration, supporting long-term business expansion.
Debt-Free Balance Sheet
A debt-free balance sheet provides financial flexibility and reduces risk, allowing the company to invest in growth opportunities without leverage concerns.
Governance Improvements
Improved governance structure can enhance operational efficiency and stakeholder trust, positively impacting long-term market positioning.
Negative Factors
Cash Flow Volatility
Volatile cash flow can strain liquidity and limit the ability to fund operations or investments, posing a risk to financial stability.
Margin Compression
Margin compression suggests rising costs or pricing pressures, which could impact profitability if not managed effectively.
Cash Flow Timing Risks
Timing risks in cash flow can affect liquidity management, potentially impacting the company's ability to meet short-term obligations.

Yantai North Andre Juice Co (2218) vs. iShares MSCI Hong Kong ETF (EWH)

Yantai North Andre Juice Co Business Overview & Revenue Model

Company DescriptionYantai North Andre Juice Co., Ltd. is a leading Chinese company specializing in the production and distribution of fruit and vegetable juices. The company primarily focuses on the processing and sale of apple juice concentrate, which is one of its core products. Operating within the food and beverage sector, Yantai North Andre Juice Co. is known for its extensive experience in fruit juice manufacturing and its strong presence in both domestic and international markets.
How the Company Makes MoneyYantai North Andre Juice Co. makes money through the production and sale of fruit and vegetable juice concentrates, with apple juice concentrate being a significant contributor to its revenue. The company sources raw fruits, which are processed into concentrates and sold to various clients, including beverage manufacturers, food companies, and wholesalers. Revenue streams include domestic sales within China and exports to international markets, where demand for high-quality juice concentrates remains robust. The company's earnings are also influenced by its ability to maintain cost-effective operations, secure favorable supply chain partnerships, and adhere to quality standards that meet the expectations of its global clientele.

Yantai North Andre Juice Co Financial Statement Overview

Summary
Strong fundamentals: TTM revenue surged (+82.3%) with solid profitability (~24% gross margin, ~20% net margin) and rising net income. Balance sheet is very conservative with zero debt and improving ROE (~12.8% TTM). Key risk is sustainability—margin compression vs. 2023 and uneven cash conversion, with negative operating/free cash flow in 2023–2024 despite profits.
Income Statement
86
Very Positive
TTM (Trailing-Twelve-Months) results show a sharp acceleration in revenue (+82.3% vs. the prior period) with strong profitability (about 24% gross margin and ~20% net margin). Net income rose meaningfully (TTM ~354M vs. 2024 ~261M) and operating profitability remains solid. The main drawback is margin compression versus 2023 (gross and net margins were materially higher then), suggesting the recent growth came with higher costs or pricing pressure.
Balance Sheet
92
Very Positive
The balance sheet is exceptionally conservative with zero total debt in TTM (Trailing-Twelve-Months) and 2024, and equity funding the vast majority of assets (TTM equity ~2.99B vs. assets ~3.19B). Returns have improved with the stronger earnings base (return on equity ~12.8% TTM vs. ~9.9% in 2024). The key limitation is that, while leverage risk is minimal, returns are good but not consistently high across the full period.
Cash Flow
70
Positive
Cash generation is strong in TTM (Trailing-Twelve-Months) with operating cash flow ~480M and free cash flow ~376M, and free cash flow running at ~78% of net income—healthy for earnings quality. However, cash flow volatility is a clear risk: both 2023 and 2024 showed negative operating and free cash flow despite positive profits, indicating working-capital swings or timing effects that can meaningfully impact liquidity in weaker periods.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.71B1.42B876.10M1.07B871.59M842.02M
Gross Profit406.83M351.53M289.04M213.14M179.67M201.02M
EBITDA351.81M299.59M299.04M230.63M148.25M154.86M
Net Income346.50M260.70M255.52M194.35M160.01M151.78M
Balance Sheet
Total Assets2.92B2.78B2.61B2.61B2.46B2.22B
Cash, Cash Equivalents and Short-Term Investments905.13M277.49M690.65M997.87M817.01M576.11M
Total Debt0.000.000.00130.09M100.06M0.00
Total Liabilities182.04M133.76M80.72M240.40M238.54M116.57M
Stockholders Equity2.73B2.65B2.53B2.37B2.23B2.11B
Cash Flow
Free Cash Flow371.14M-271.55M-162.67M185.29M119.31M158.39M
Operating Cash Flow473.83M-109.20M-29.85M240.73M194.02M211.25M
Investing Cash Flow-267.84M-52.64M572.42M-377.58M-66.22M
Financing Cash Flow-201.68M-144.56M-226.59M-33.12M65.09M43.54M

Yantai North Andre Juice Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price15.85
Price Trends
50DMA
14.25
Positive
100DMA
15.41
Negative
200DMA
15.61
Negative
Market Momentum
MACD
0.26
Negative
RSI
66.39
Neutral
STOCH
88.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2218, the sentiment is Positive. The current price of 15.85 is above the 20-day moving average (MA) of 14.11, above the 50-day MA of 14.25, and above the 200-day MA of 15.61, indicating a neutral trend. The MACD of 0.26 indicates Negative momentum. The RSI at 66.39 is Neutral, neither overbought nor oversold. The STOCH value of 88.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2218.

Yantai North Andre Juice Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$12.85B13.3912.70%1.98%38.54%49.91%
72
Outperform
HK$1.01B8.425.08%10.44%-1.19%-9.05%
68
Neutral
HK$2.30B10.3313.72%3.74%11.89%27.80%
67
Neutral
HK$7.26B34.965.55%1.41%7.29%-33.19%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
HK$7.42B11.396.29%100.45%2.89%
39
Underperform
HK$114.09M-4.267.09%16.29%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2218
Yantai North Andre Juice Co
14.98
6.44
75.39%
HK:0756
Summi (Group) Holdings Limited
0.34
-0.66
-66.16%
HK:1475
Nissin Foods Co., Ltd.
6.99
1.26
21.99%
HK:1610
COFCO Joycome Foods Limited
1.62
0.27
20.00%
HK:1837
Natural Food International Holding Ltd.
1.05
0.59
128.26%
HK:2317
Vedan International (Holdings) Ltd.
0.66
0.22
50.00%

Yantai North Andre Juice Co Corporate Events

Yantai North Andre Juice Cancels 7 Million Repurchased H Shares, Tightening Share Capital Base
Dec 30, 2025

Yantai North Andre Juice Co., Ltd. has completed a substantial repurchase and cancellation of its H shares under a general mandate approved at its 2024 annual general meeting. Between June and late December 2025, the company executed 21 repurchase transactions, buying back an aggregate 7,012,000 H shares for a total consideration of HK$121.8 million, equal to about 9.92% of its issued H shares and 2.06% of total share capital at the time the mandate was granted. These repurchased shares were formally cancelled on 30 December 2025, reducing total share capital from 341.2 million to 334.188 million shares and decreasing the proportion of H shares from 20.71% to 19.05%, while A shares rose proportionally to 80.95%. The move tightens the company’s share base and may enhance per‑share metrics, while slightly shifting the ownership structure away from Hong Kong-listed H shares toward its domestic A shares.

Yantai North Andre Juice Co. Releases 2025 Q3 Report
Oct 29, 2025

Yantai North Andre Juice Co., Ltd. released its unaudited third quarterly report for 2025, covering the nine months ending September 30, 2025. The report, prepared according to PRC Accounting Standards, assures stakeholders of its accuracy and completeness, despite not being audited. The announcement underscores the company’s commitment to transparency and regulatory compliance, potentially impacting its market perception and stakeholder trust.

Yantai North Andre Juice Co. Approves Key Governance Amendments at EGM
Oct 28, 2025

Yantai North Andre Juice Co., Ltd. announced the successful passing of all resolutions at its 2025 second extraordinary general meeting. The resolutions included significant amendments to the company’s Articles of Association, Rules of Procedure, and various management systems, reflecting a strategic shift in governance and operational protocols. These changes are expected to enhance the company’s governance structure and operational efficiency, potentially impacting its market positioning and stakeholder relations positively.

Yantai North Andre Juice Co. Schedules Board Meeting for Quarterly Results
Oct 19, 2025

Yantai North Andre Juice Co., Ltd. has announced that its board of directors will meet on October 29, 2025, to review and approve the unaudited consolidated third quarterly results for the nine months ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025